KORU Medical Systems Inc. (KRMD)
(Delayed Data from NSDQ)
$2.19 USD
-0.01 (-0.45%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $2.20 +0.01 (0.46%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum B VGM
Income Statements
Fiscal Year end for KORU Medical Systems Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 29 | 28 | 23 | 24 | 23 |
Cost Of Goods | 12 | 13 | 10 | 9 | 8 |
Gross Profit | 17 | 15 | 14 | 15 | 15 |
Selling & Adminstrative & Depr. & Amort Expenses | 27 | 26 | 21 | 16 | 14 |
Income After Depreciation & Amortization | -10 | -11 | -7 | -1 | 1 |
Non-Operating Income | 1 | 0 | 1 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -10 | -11 | -6 | -1 | 1 |
Income Taxes | 4 | -2 | -2 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -14 | -9 | -5 | -1 | 1 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -14 | -9 | -5 | -1 | 1 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -9 | -10 | -7 | -1 | 1 |
Depreciation & Amortization (Cash Flow) | 1 | 1 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -10 | -11 | -7 | -1 | 1 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 45.60 | 45.00 | 44.39 | 41.93 | 39.06 |
Diluted EPS Before Non-Recurring Items | -0.13 | -0.16 | -0.07 | 0.02 | 0.01 |
Diluted Net EPS (GAAP) | -0.30 | -0.19 | -0.10 | -0.03 | 0.01 |
Fiscal Year end for KORU Medical Systems Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 7.19 | 7.00 | 6.94 | 7.39 |
Cost Of Goods | NA | 2.85 | 2.66 | 3.05 | 3.25 |
Gross Profit | NA | 4.33 | 4.34 | 3.89 | 4.15 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 6.53 | 6.13 | 7.11 | 7.20 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -2.20 | -1.79 | -3.22 | -3.05 |
Non-Operating Income | NA | 0.18 | 0.12 | 0.13 | 0.07 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -2.02 | -1.67 | -3.10 | -2.99 |
Income Taxes | NA | 5.45 | -0.30 | -0.60 | -0.58 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -7.47 | -1.37 | -2.50 | -2.41 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -7.47 | -1.37 | -2.50 | -2.41 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 45.67 | 45.64 | 45.61 | 45.49 |
Diluted EPS Before Non-Recurring Items | NA | -0.02 | -0.03 | -0.05 | -0.05 |
Diluted Net EPS (GAAP) | NA | -0.17 | -0.03 | -0.05 | -0.05 |